GAMMA Investing’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
GAMMA Investing's BIOA Position: Q3 2026 in Review
GAMMA Investing increased its BioAge Labs (BIOA) stake by 1,889% in Q3 2026, buying an estimated $2.36K and bringing the position to 179 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #4056.
GAMMA Investing first reported a position in BIOA in Q1 2026 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- GAMMA Investing held 179 shares of BioAge Labs worth $1.27K as of Q3 2026.
- GAMMA Investing bought 170 BioAge Labs shares in Q3 2026, an estimated $2.36K.
- BioAge Labs made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4056 holding.
- GAMMA Investing first reported a position in BioAge Labs in Q1 2026 and has held it in 3 quarters since.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.